fr   en
Clinical Studies



Browse by date
Or search by keyword
Date: 2006-02-24
Phase: I
Anouncement: Launch
Biotech: IDM Pharma (France)
Pharma:  
Product: Junovan® (a synthetic derivative of muramyl pentapeptide)
Disease: osteosarcoma
Country:  
Other: The phase III study is underway and the MAA is planned for 2007